The Qt Company Ltd (“The Qt Company”), a wholly owned subsidiary of Qt Group Plc, has announced a public tender offer to the shareholders of I.A.R. Systems Group AB (publ) (“IAR”) to tender all class B shares in IAR to The Qt Company at a price of SEK 180 in cash per share

IAR provides software and services for embedded development used by companies worldwide for creation of secure products. Headquartered in Uppsala, Sweden, IAR has a global presence of sales and support offices worldwide. The shares in IAR are traded on Nasdaq Stockholm, Mid Cap. The offer values IAR at approximately SEK 2,293 million.


Vinge’s team mainly consists of Rikard Lindahl, Erik Sjöman, Joel Magnusson, Benjamin Vafaeian, Louise Nässén and Vilma Henricsson (Capital Markets and Public M&A), Jonas Johansson (M&A), Arvid Weimers, Josefine Lanker, Nour Makie and Katja Häglund (Banking and Finance), Johanna Fjellström and Alice Göransson (Labor Law), Rebecka Målquist and Melinda Oldenburg (IP), Eva Fredrikson, Martin Boström, Siri Blomberg and Filippa Eriksson (Commercial agreements, IT and GDPR), Fredrik Hellström and Lovisa Arpi (FDI), Gulestan Ali (Compliance) and Diana Kanold (VDR).

Related

Vinge advised Precise Biometrics

Vinge has advised Precise Biometrics AB in connection with the merger with Fingerprint Cards.
March 27, 2026

Vinge has advised Xspray Pharma in connection with its rights issue

Vinge has advised Xspray Pharma AB (publ) in connection with a rights issue of approximately SEK 83 million before transaction costs, with an over-allotment issue of approximately SEK 30 million.
March 26, 2026

Vinge advises Diamyd Medical in connection with directed issuances of shares and warrants of up to SEK 1,166 million

Vinge advises Diamyd Medical Aktiebolag (“Diamyd Medical”), listed on Nasdaq First North Growth Market, in connection with directed issuances of shares and warrants whereby Diamyd Medical receives gross proceeds of approximately SEK 1,166 million, if all warrants are exercised.
March 25, 2026